---
$id: https://graph.org.ai/products/commodity/51113602
$type: Product
source: UNSPSC
code: "51113602"
title: "Oprelvekin"
class: "51113600"
classTitle: "Alkylating agent cytokines"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Oprelvekin

**UNSPSC Code**: 51113602
**Class**: [Alkylating agent cytokines](Alkylating agent cytokines.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic interleukin with the molecular formula C854H1411N253O235S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) HM5641GA6F, more generally known as oprelvekin. European Medicines Agency schedules oprelvekin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14704MIG. The term OPRELVEKIN is an International Non-Proprietary Name or INN. see World Health Organization INN reference publication, Volume 11, no. 3 1997, list 38. OPRELVEKIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oprelvekin under HS 30021095 and SITC 54163. As of Q4 2014, OPRELVEKIN remains the US FDA Preferred Term for this commodity. Oprelvekin bears US NLM identifiers UMLS ID C0537670 and NCI Concept Code C1303.

